Key result
CLCN1 mutation type is related to CMAP decrement in myotonia congenita, with decrements of 30-84% in P480L and 20-47% in R894X mutations, but absent in M128V and E193K mutations.
Why the study?
Is the decrement of compound muscle action potential related to CLCN1 mutation type in myotonia congenita?
Observational
Is the decrement of compound muscle action potential related to CLCN1 mutation type in myotonia congenita?
CMAP decrement during repetitive nerve stimulation can be pronounced in dominant myotonia congenita and is dependent on the specific CLCN1 mutation type.
Answers are grounded in this paper and cite their sources.
Supports genotype-informed CMAP assessment in myotonia congenita; extends observational correlations but leaves open prospective validation.
Decrement of the compound muscle action potential (CMAP) during 10-HZ repetitive nerve stimulation is thought to be an unusual finding in dominant myotonia congenita, and has not previously been reported in patients with the genetically verified disorder. It was the purpose of the present study to elucidate the relation between decrement and CLCN1 mutation type in myotonia congenita. Decrement and genotypes were studied in eight Danish families with myotonia congenita. Six patients with the known dominant mutation P480L had decrements of 30-84%. Patients heterozygous for the R894X mutation had decrements of 20-47%. Three novel CLCN1 mutations (two dominant and one recessive) were found segregating with the Thomsen/Becker phenotypes. In families with the novel dominant mutations M128V and E193K, decrement was absent in all family members tested. In conclusion, CMAP decrement may be pronounced in dominant myotonia congenita, and the presence of decrement is related to mutation type.
No takes yet. Share an insight, caveat, or question.
Colding‐Jørgensen et al. (2003) conducted an observational in Myotonia congenita. CLCN1 mutation type vs. Other mutation types was evaluated on Decrement of the compound muscle action potential (CMAP) during 10-Hz repetitive nerve stimulation. CLCN1 mutation type is related to CMAP decrement in myotonia congenita, with decrements of 30-84% in P480L and 20-47% in R894X mutations, but absent in M128V and E193K mutations.
Synapse has enriched 10 related papers. Consider them for comparative context: